Heart failure and hypertrophic cardiomyopathy

PheWeb

I9_HEARTFAIL_AND_HYPERTCARDIOM

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions

I9_HYPERTROCARDMYOP

839

Filter registries None

Check pre-conditions, main-only, mode, ICD version None

Check minimum number of events None

Include endpoints

I9_HEARTFAIL

337

I9_HEARTFAIL_AND_HYPERTCARDIOM

Extra metadata

First used in FinnGen datafreeze DF5

Similar endpoints

↥

List of similar endpoints to Heart failure and hypertrophic cardiomyopathy based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	326	115	211
Unadjusted prevalence (%)	0.11	0.07	0.16
Mean age at first event (years)	59.63	60.55	59.12

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: I9_HEARTFAIL_AND_HYPERTCARDIOM – Heart failure and hypertrophic cardiomyopathy
GWS hits: 4

Survival analyses between endpoints

↥

Plot

before Heart failure and hypertrophic cardiomyopathy
after Heart failure and hypertrophic cardiomyopathy

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Heart failure and hypertrophic cardiomyopathy

↥